January 21, 2025

Vedran Beglerbegovic has today informed the Board of Directors that he is resigning from the position as CEO of SyntheticMR due to medical reasons.

The board has appointed CFO Johanna Norén as Acting CEO. The board will begin a recruitment process for a new CEO.

For more information, please contact:

Staffan Persson, Chairman, tel. +46 70-321 00 98

Johanna Norén, Acting CEO, tel. +46 70 619 21 00

This disclosure contains information that SyntheticMR AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 21-01-2025 20:28 CET.

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI^®, delivering multiple, adjustable contrast images and quantitative data from a single 5-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for knee and spine anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is CE-marked. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden. For more information, visit www.syntheticmr.com.